Company / Gross Profit
Biogen Gross Profit History
FY2016-FY2020 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Gross Profit
$11.6B
FY2020
5-year range
-
FY2016-FY2020
Trend
-6.3%
vs FY2019
Sector context
#2 of 27
Health Care
What the data says
Among 27 Health Care companies, Biogen is in the top 7% for gross profit.
Based on SEC 10-K filings.
$11.6B in FY2020 with a 3-year CAGR of +3.0%. Ranks 2nd among 27 companies in Health Care.
Remained stable around $11.6B over the past 2 years.
Health Care sector context is included.
Gross Profit over time
Growth rates
- 3-Year CAGR
- +3.0%
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
Top 7% in Health CareTop 7% of 27This company $11.6B Sector average $3.7B
▼
+215.5% above sector average
Key checks
Key Insights
- 3-year CAGR of +3.0%, indicating consistent growth.
- In FY2020, gross profit decreased 6.3% year-over-year.
- Ranks #2 out of 27 companies in the Health Care sector.
- Peak gross profit was recorded in FY2019.
Company context
Key Data Points
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Gross ProfitValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | - | - |
| FY2024 | - | - |
| FY2023 | - | - |
| FY2022 | - | - |
| FY2021 | - | - |
| FY2020 | $11.6B | -6.3% |
| FY2019 | $12.4B | +6.8% |
| FY2018 | $11.6B | +9.3% |
| FY2017 | $10.6B | +6.8% |
| FY2016 | $10.0B | +4.7% |
As of FY2020 · SEC 10-K · Updated Mar 3, 2026